Prof. Zhifeng Huang
Dr. Zhifeng Huang obtained B.Sc. in Chemistry (in 2000) and M.Sc. in Physical Chemistry (in 2003) at Xiamen University (China), and Ph.D. in Science and Engineering of Materials at Arizona State University (US, 2007). After working as a postdoctoral fellow in Department of Electrical and Computing Engineering at University of Alberta (Canada, Jan. 2008 – Aug. 2009), Dr. Huang joined Department of Physics at Hong Kong Baptist University (HKBU) as an Assistant Professor, and was promoted to Associate Professor in 2015.
Dr. Huang is Associate Director (Nanomaterials) in Golden Meditech Centre for NeuroRegeneration Sciences at HKBU, is Member of The Hong Kong Young Academy of Sciences, and serves as Vice President in Hong Kong Materials Research Society.
Dr. Huang is devoted to fabricating sculptured nano thin films to study chiral nanoplasmonics, surface enhanced chiroptical spectroscopies, enantioselective synthesis, photochirogenesis, enantiodifferentiation, trace (bio)molecular detection, bio-nano interaction, specific differentiation of stem cells, functional optic coating, and flexible/wearable energy generation and storage. He contributed to two book chapters, and published his studies in high-impact journals, such as Nat. Nanotechnol., Annu. Rev. Phys. Chem., Adv. Mater., Adv. Funct. Mater., Nano Lett., J. Am. Chem. Soc., Adv. Sci., Small, and Nanoscale.
Dr. Huang was presented 2019 TechConnect Innovation Award, Gold Medal with Congratulations of Jury (The 46th International Exhibition of Inventions of Geneva, 2018), Outstanding Research Achievement (APSMR, 2017 and 2018), the Prof. Rudolph A. Marcus Award 2016, the Incentive Award for Outstanding Research Achievement (Faculty of Science, HKBU, 2015), and National-level Technology Project Award for Advanced Individual (2012, 2014). He is serving as Review Editor for Frontiers in Chemistry, Associate Editor for Science Advances Today and Science Letters Journal (Cognizure).
Dr. Huang, together with Prof. Ken Yung (Department of Biology, HKBU), co-founded a spin-off, Mat-A-Cell Ltd., to commercialize a new-generation medical device for cell culture.